148 related articles for article (PubMed ID: 15290006)
1. Bimodal effects of MK-801 on locomotion and stereotypy in C57BL/6 mice.
Wu J; Zou H; Strong JA; Yu J; Zhou X; Xie Q; Zhao G; Jin M; Yu L
Psychopharmacology (Berl); 2005 Jan; 177(3):256-63. PubMed ID: 15290006
[TBL] [Abstract][Full Text] [Related]
2. Age-related differential sensitivity to MK-801-induced locomotion and stereotypy in C57BL/6 mice.
Qi C; Zou H; Zhang R; Zhao G; Jin M; Yu L
Eur J Pharmacol; 2008 Feb; 580(1-2):161-8. PubMed ID: 18053981
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical effects of very low dose MK-801.
Tang Y; Zou H; Strong JA; Cui Y; Xie Q; Zhao G; Jin M; Yu L
Eur J Pharmacol; 2006 May; 537(1-3):77-84. PubMed ID: 16626696
[TBL] [Abstract][Full Text] [Related]
4. Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine (MK-801), but not methamphetamine.
Ito K; Abekawa T; Koyama T
Psychopharmacology (Berl); 2006 Jul; 186(4):525-33. PubMed ID: 16758239
[TBL] [Abstract][Full Text] [Related]
5. Effect of GNTI, a kappa opioid receptor antagonist, on MK-801-induced hyperlocomotion and stereotypy in mice.
Qi CT; Zou H; Zhang CH; Xie QL; Jin ML; Yu L
Acta Pharmacol Sin; 2006 Nov; 27(11):1401-8. PubMed ID: 17049114
[TBL] [Abstract][Full Text] [Related]
6. MK-801 suppresses muricidal behavior but not locomotion in olfactory bulbectomized rats: involvement of NMDA receptors.
Ho YJ; Chen KH; Tai MY; Tsai YF
Pharmacol Biochem Behav; 2004 Mar; 77(3):641-6. PubMed ID: 15006477
[TBL] [Abstract][Full Text] [Related]
7. Preferential blockade by clozapine of hyperlocomotion induced by non-competitive NMDA antagonist MK-801.
Ninan I; Kulkarni SK
Indian J Physiol Pharmacol; 1998 Jul; 42(3):375-82. PubMed ID: 9741652
[TBL] [Abstract][Full Text] [Related]
8. 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion.
Ninan I; Kulkarni SK
Eur J Pharmacol; 1998 Oct; 358(2):111-6. PubMed ID: 9808259
[TBL] [Abstract][Full Text] [Related]
9. Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine.
Ninan I; Kulkarni SK
Eur J Pharmacol; 1999 Feb; 368(1):1-7. PubMed ID: 10096763
[TBL] [Abstract][Full Text] [Related]
10. The effect of neonatal N-methyl-D-aspartate receptor blockade on exploratory and anxiety-like behaviors in adult BALB/c and C57BL/6 mice.
Akillioglu K; Binokay S; Kocahan S
Behav Brain Res; 2012 Jul; 233(1):157-61. PubMed ID: 22562039
[TBL] [Abstract][Full Text] [Related]
11. Effect of subchronic caffeine treatment on MK-801-induced changes in locomotion, cognition and ataxia in mice.
de Oliveira RV; Dall'Igna OP; Tort AB; Schuh JF; Neto PF; Santos Gomes MW; Souza DO; Lara DR
Behav Pharmacol; 2005 Mar; 16(2):79-84. PubMed ID: 15767842
[TBL] [Abstract][Full Text] [Related]
12. Effects of non-competitive NMDA receptor antagonists on reproductive and motor behaviors in female rats.
Fleischmann A; Vincent PA; Etgen AM
Brain Res; 1991 Dec; 568(1-2):138-46. PubMed ID: 1839964
[TBL] [Abstract][Full Text] [Related]
13. Effects of zotepine, haloperidol and clozapine on MK-801-induced stereotypy and locomotion in rats.
Gattaz WF; Schummer B; Behrens S
J Neural Transm Gen Sect; 1994; 96(3):227-32. PubMed ID: 7826573
[TBL] [Abstract][Full Text] [Related]
14. An Orally Active Phenylaminotetralin-Chemotype Serotonin 5-HT7 and 5-HT1A Receptor Partial Agonist that Corrects Motor Stereotypy in Mouse Models.
Canal CE; Felsing DE; Liu Y; Zhu W; Wood JT; Perry CK; Vemula R; Booth RG
ACS Chem Neurosci; 2015 Jul; 6(7):1259-70. PubMed ID: 26011730
[TBL] [Abstract][Full Text] [Related]
15. Neurobehavioral Differences of Valproate and Risperidone on MK-801 Inducing Acute Hyperlocomotion in Mice.
Chen PA; Wang HY; Sun CL; Chen ML; Chen YC
Behav Neurol; 2022; 2022():1048463. PubMed ID: 35251367
[TBL] [Abstract][Full Text] [Related]
16. Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine.
Ito K; Abekawa T; Koyama T
Psychopharmacology (Berl); 2006 Aug; 187(3):293-302. PubMed ID: 16850286
[TBL] [Abstract][Full Text] [Related]
17. Critical involvement of the orbitofrontal cortex in hyperlocomotion induced by NMDA receptor blockade in mice.
Seiriki K; Kasai A; Kuwaki T; Nakazawa T; Yamaguchi S; Hashimoto H
Biochem Biophys Res Commun; 2016 Nov; 480(4):558-563. PubMed ID: 27793672
[TBL] [Abstract][Full Text] [Related]
18. Chronic treatment with caffeine blunts the hyperlocomotor but not cognitive effects of the N-methyl-D-aspartate receptor antagonist MK-801 in mice.
Dall'Igna OP; Da Silva AL; Dietrich MO; Hoffmann A; de Oliveira RV; Souza DO; Lara DR
Psychopharmacology (Berl); 2003 Mar; 166(3):258-63. PubMed ID: 12589526
[TBL] [Abstract][Full Text] [Related]
19. The topography of MK-801-induced locomotor patterns in rats.
Ford LM; Norman AB; Sanberg PR
Physiol Behav; 1989 Oct; 46(4):755-8. PubMed ID: 2557649
[TBL] [Abstract][Full Text] [Related]
20. Guanosine selectively inhibits locomotor stimulation induced by the NMDA antagonist dizocilpine.
Tort AB; Mantese CE; dos Anjos GM; Dietrich MO; Dall'Igna OP; Souza DO; Lara DR
Behav Brain Res; 2004 Oct; 154(2):417-22. PubMed ID: 15313029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
